Cure Hepatitis C Act of 2025
Sens. Cassidy and Van Hollen Push Bipartisan Bill to Provide Free Hepatitis C Cures
The Cure Hepatitis C Act of 2025 was introduced in the Senate and is currently being reviewed by the Committee on Health, Education, Labor, and Pensions. No further actions are scheduled at this time. The bill is in the early stages of the legislative process.
Legislative Progress
The bill has strong bipartisan leaders but carries a high cost and introduces a new way for the government to buy drugs that some may oppose.
Key Points
Impact Analysis
Personal Impact
Life & Work
Undocumented immigrants are explicitly excluded from receiving hepatitis C treatment through this program. The bill limits eligibility to U.S. citizens, lawful permanent residents, refugees, asylees, and certain other authorized immigrant groups. This means undocumented individuals with hepatitis C would not benefit from the free treatment, even though they may be part of high-risk populations.
“the amounts appropriated pursuant to this Act and the amendments made by this Act may only be used to carry out the provisions of this Act with respect to an individual who is-- (1) a citizen of the United States”
Programs
Disabilities
Milestones
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
Related News
5 articlesThe Cure Hepatitis C Act Of 2025: Critical questions and policy design considerations
This article explores the 'Netflix model' subscription program proposed in the Cure Hepatitis C Act of 2025, which allocates $5.5 billion for drug procurement and $4.3 billion for public health activities to eliminate the virus by 2031 through unlimited treatment access at a fixed annual price.
Cure Hepatitis C Act 2025: US Strategy to End Hepatitis C
Senators Bill Cassidy and Chris Van Hollen introduced S.1941 to codify federal efforts to eliminate HCV. The bill mandates a subscription purchasing model for curative therapies and removes cost-sharing for Medicare beneficiaries while prioritizing high-burden populations like those in prisons.
Senators Introduce Bill Aimed to Support Fight to Cure Hep C
The bipartisan Cure Hepatitis C Act of 2025 aims to save $6.6 billion in taxpayer dollars by establishing a voluntary drug subscription model. The program is designed to provide curative treatments to low-income and hard-to-reach Americans, including those in the Indian Health Program.
Source Information
Document Type
Congressional Bill
Official Title
Cure Hepatitis C Act of 2025
Data Sources
Sponsor
Cosponsors
(1)Analysis generated by AI. Always verify with official sources.